Evaluation of cell penetrating peptides fused to elastin-like polypeptide for drug delivery

Journal of Controlled Release

Volumn 108, Issue 2-3, 2005, Pages 396-408

  Massodi, Iqbal ^a   Bidwell III, Gene L ^a   Raucher, Drazen ^a  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

Cell penetrating peptide; Drug delivery; Elastin like polypeptide; Penetratin; Tat

Indexed keywords

BIOPOLYMERS; CELLS; CYTOLOGY; DRUG DOSAGE; MACROMOLECULES; PROTEINS;

CELL PENETRATING PEPTIDES; DRUG DELIVERY; ELASTIN-LIKE POLYPEPTIDES; PENETRATIN; TAT;

POLYPEPTIDES;

ADENOSINE TRIPHOSPHATE; CYCLIN DEPENDENT KINASE INHIBITOR; ELASTIN LIKE POLYPEPTIDE; MEMBRANE TRANSLOCATING SEQUENCE FROM KAPOSI FIBROBLAST GROWTH FACTOR; PENETRATIN; PEPTIDE; POLYPEPTIDE; PROTEIN P21; SUCROSE; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CELL PROLIFERATION; CELL STRAIN; CELL STRAIN SKOV 3; CONFOCAL MICROSCOPY; DRUG DELIVERY SYSTEM; DRUG PENETRATION; DRUG TRANSPORT; ENDOCYTOSIS; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; HELA CELL; HUMAN; HUMAN CELL; HYPEROSMOLARITY; PRIORITY JOURNAL;

ADENOSINE TRIPHOSPHATE; AMINO ACID SEQUENCE; ANIMALS; CELL LINE, TUMOR; CELL PROLIFERATION; DRUG DELIVERY SYSTEMS; ELASTIN; ENDOCYTOSIS; FLUORESCENT DYES; HUMANS; KINETICS; MICROSCOPY, CONFOCAL; MOLECULAR SEQUENCE DATA; PEPTIDES; TEMPERATURE;

EID: 27744525788     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2005.08.007     Document Type: Article

References (39)

1. R. Langer Drug delivery and targeting Nature (Lond.) 392 1998 5 10 (Suppl.)
2. R. Duncan The dawning era of polymer therapeutics Nat. Rev. Drug Discov. 2 2003 347 360
3. H. Maeda, L.W. Seymour, and Y. Miyamoto Conjugates of anticancer agents and polymers: advantages of macromolecular therapeutics in vivo Bioconjug. Chem. 3 1992 351 362
4. T. Minko, P. Kopeckova, V. Pozharov, and J. Kopecek HPMA copolymer bound adriamycin overcomes MDR1 gene encoded resistance in a human ovarian carcinoma cell line J. Control. Release 54 1998 223 233
5. Y. Takakura, T. Fujita, M. Hashida, and H. Sezaki Disposition characteristics of macromolecules in tumor-bearing mice Pharm. Res. 7 1990 339 346
6. T. Yamaoka, Y. Tabata, and Y. Ikada Distribution and tissue uptake of poly(ethylene glycol) with different molecular weights after intravenous administration to mice J. Pharm. Sci. 83 1994 601 606
7. D.E. Meyer, B.C. Shin, G.A. Kong, M.W. Dewhirst, and A. Chilkoti Drug targeting using thermally responsive polymers and local hyperthermia J. Control. Release 74 2001 213 224
8. D.E. Meyer, G.A. Kong, M.W. Dewhirst, M.R. Zalutsky, and A. Chilkoti Targeting a genetically engineered elastin-like polypeptide to solid tumors by local hyperthermia Cancer Res. 61 2001 1548 1554
9. A. Graslund, and L.E. Eriksson Properties and applications of cell-penetrating peptides Genet. Eng. (N Y) 26 2004 19 31
10. A. Nori, and J. Kopecek Intracellular targeting of polymer-bound drugs for cancer chemotherapy Adv. Drug Deliv. Rev. 57 2005 609 636
11. E.L. Snyder, and S.F. Dowdy Cell penetrating peptides in drug delivery Pharm. Res. 21 2004 389 393
12. J. Temsamani, and P. Vidal The use of cell-penetrating peptides for drug delivery Drug Discov. Today 9 2004 1012 1019
13. D. Derossi, A.H. Joliot, G. Chassaing, and A. Prochiantz The third helix of the Antennapedia homeodomain translocates through biological membranes J. Biol. Chem. 269 1994 10444 10450
14. B.S. Weeks, K. Desai, P.M. Loewenstein, M.E. Klotman, P.E. Klotman, M. Green, and H.K. Kleinman Identification of a novel cell attachment domain in the HIV-1 Tat protein and its 90-kDa cell surface binding protein J. Biol. Chem. 268 1993 5279 5284
15. J. Hawiger Noninvasive intracellular delivery of functional peptides and proteins Curr. Opin. Chem. Biol. 3 1999 89 94
16. M. Mutoh, F.D. Lung, Y.Q. Long, P.P. Roller, R.S. Sikorski, and P.M. O'Connor A p21(Waf1/Cip1)carboxyl-terminal peptide exhibited cyclin-dependent kinase-inhibitory activity and cytotoxicity when introduced into human cells Cancer Res. 59 1999 3480 3488
17. A. Chilkoti, M.R. Dreher, and D.E. Meyer Design of thermally responsive, recombinant polypeptide carriers for targeted drug delivery Adv. Drug Deliv. Rev. 54 2002 1093 1111
18. D.E. Meyer, and A. Chilkoti Genetically encoded synthesis of protein-based polymers with precisely specified molecular weight and sequence by recursive directional ligation: examples from the elastin-like polypeptide system Biomacromolecules 3 2002 357 367
19. D.E. Meyer, and A. Chilkoti Purification of recombinant proteins by fusion with thermally responsive polypeptides Nat. Biotechnol. 17 1999 1112 1115
20. G.L. Bidwell III, and D. Raucher Application of thermally responsive polypeptides directed against c-Myc transcriptional function for cancer therapy Mol. Cancer Ther. 4 2005 1076 1085
21. D. Raucher, and A. Chilkoti Enhanced uptake of a thermally responsive polypeptide by tumor cells in response to its hyperthermia-mediated phase transition Cancer Res. 61 2001 7163 7170
22. J. Hed, G. Hallden, S.G. Johansson, and P. Larsson The use of fluorescence quenching in flow cytofluorometry to measure the attachment and ingestion phases in phagocytosis in peripheral blood without prior cell separation J. Immunol. Methods 101 1987 119 125
23. X. Wu, X. Zhao, L. Baylor, S. Kaushal, E. Eisenberg, and L.E. Greene Clathrin exchange during clathrin-mediated endocytosis J. Cell Biol. 155 2001 291 300
24. P. Saalik, A. Elmquist, M. Hansen, K. Padari, K. Saar, K. Viht, U. Langel, and M. Pooga Protein cargo delivery properties of cell-penetrating peptides. A comparative study Bioconjug. Chem. 15 2004 1246 1253
25. C.A. Casey, R.L. Wiegert, and D.J. Tuma Effect of hyperosmolarity on both receptor-mediated and fluid-phase endocytosis in ethanol-fed animals Biochem. Pharmacol. 49 1995 1117 1123
26. M.L. Torgersen, G. Skretting, B. van Deurs, and K. Sandvig Internalization of cholera toxin by different endocytic mechanisms J. Cell Sci. 114 2001 3737 3747
27. J. Thyberg Caveolae and cholesterol distribution in vascular smooth muscle cells of different phenotypes J. Histochem. Cytochem. 50 2002 185 195
28. B. van Deurs, O.W. Petersen, S. Olsnes, and K. Sandvig The ways of endocytosis Int. Rev. Cytol. 117 1989 131 177
29. K. Sandvig, and B. van Deurs Endocytosis without clathrin Trends Cell Biol. 4 1994 275 277
30. J.E. Heuser, and R.G. Anderson Hypertonic media inhibit receptor-mediated endocytosis by blocking clathrin-coated pit formation J. Cell Biol. 108 1989 389 400
31. D. Rousseau, D. Cannella, J. Boulaire, P. Fitzgerald, A. Fotedar, and R. Fotedar Growth inhibition by CDK-cyclin and PCNA binding domains of p21 occurs by distinct mechanisms and is regulated by ubiquitin-proteasome pathway Oncogene 18 1999 4313 4325
32. S. Sahlin, J. Hed, and I. Rundquist Differentiation between attached and ingested immune complexes by a fluorescence quenching cytofluorometric assay J. Immunol. Methods 60 1983 115 124
33. M. Hallbrink, A. Floren, A. Elmquist, M. Pooga, T. Bartfai, and U. Langel Cargo delivery kinetics of cell-penetrating peptides Biochim. Biophys. Acta 1515 2001 101 109
34. T.B. Potocky, A.K. Menon, and S.H. Gellman Cytoplasmic and nuclear delivery of a TAT-derived peptide and a beta-peptide after endocytic uptake into HeLa cells J. Biol. Chem. 278 2003 50188 50194
35. B. Christiaens, J. Grooten, M. Reusens, A. Joliot, M. Goethals, J. Vandekerckhove, A. Prochiantz, and M. Rosseneu Membrane interaction and cellular internalization of penetratin peptides Eur. J. Biochem. 271 2004 1187 1197
36. P. Lundberg, and U. Langel A brief introduction to cell-penetrating peptides J. Mol. Recognit. 16 2003 227 233
37. M. Silhol, M. Tyagi, M. Giacca, B. Lebleu, and E. Vives Different mechanisms for cellular internalization of the HIV-1 Tat-derived cell penetrating peptide and recombinant proteins fused to Tat Eur. J. Biochem. 269 2002 494 501
38. T.K. Sawyer Cancer metastasis therapeutic targets and drug discovery: emerging small-molecule protein kinase inhibitors Expert Opin. Investig. Drugs 13 2004 1 19
39. Q. Li, and W. Xu Novel anticancer targets and drug discovery in post genomic age Curr. Med. Chem. Anti-Canc. Agents 5 2005 53 63